SABRA HEALTH CARE REIT INC (SBRA) Stock Fundamental Analysis
USA - NASDAQ:SBRA - US78573L1061 - REIT
18.59 USD
-0.06 (-0.32%)
18.57 USD
-0.02 (-0.11%)
We assign a fundamental rating of 6 out of 10 to SBRA. SBRA was compared to 128 industry peers in the Diversified REITs industry. SBRA has an average financial health and profitability rating. SBRA is growing strongly while it is still valued neutral. This is a good combination! These ratings would make SBRA suitable for growth investing!
1. Profitability
1.1 Basic Checks
SBRA had positive earnings in the past year.
SBRA had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: SBRA reported negative net income in multiple years.
Each year in the past 5 years SBRA had a positive operating cash flow.
1.2 Ratios
SBRA's Return On Assets of 3.15% is fine compared to the rest of the industry. SBRA outperforms 78.13% of its industry peers.
SBRA has a Return On Equity of 6.20%. This is in the better half of the industry: SBRA outperforms 75.00% of its industry peers.
SBRA has a better Return On Invested Capital (3.87%) than 74.22% of its industry peers.
SBRA had an Average Return On Invested Capital over the past 3 years of 3.52%. This is in line with the industry average of 3.04%.
The last Return On Invested Capital (3.87%) for SBRA is above the 3 year average (3.52%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.15% | ||
| ROE | 6.2% | ||
| ROIC | 3.87% |
ROA(3y)0.43%
ROA(5y)0.34%
ROE(3y)0.86%
ROE(5y)0.66%
ROIC(3y)3.52%
ROIC(5y)3.4%
1.3 Margins
The Profit Margin of SBRA (23.50%) is better than 75.00% of its industry peers.
SBRA's Profit Margin has improved in the last couple of years.
SBRA has a better Operating Margin (35.78%) than 75.00% of its industry peers.
SBRA's Operating Margin has declined in the last couple of years.
SBRA has a Gross Margin (68.38%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of SBRA has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 35.78% | ||
| PM (TTM) | 23.5% | ||
| GM | 68.38% |
OM growth 3Y-0.95%
OM growth 5Y-4.46%
PM growth 3YN/A
PM growth 5Y9.21%
GM growth 3Y-4.03%
GM growth 5Y-3.89%
2. Health
2.1 Basic Checks
SBRA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
SBRA has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, SBRA has more shares outstanding
SBRA has a worse debt/assets ratio than last year.
2.2 Solvency
SBRA has an Altman-Z score of 0.81. This is a bad value and indicates that SBRA is not financially healthy and even has some risk of bankruptcy.
SBRA's Altman-Z score of 0.81 is fine compared to the rest of the industry. SBRA outperforms 67.97% of its industry peers.
The Debt to FCF ratio of SBRA is 168.41, which is on the high side as it means it would take SBRA, 168.41 years of fcf income to pay off all of its debts.
SBRA has a better Debt to FCF ratio (168.41) than 60.94% of its industry peers.
SBRA has a Debt/Equity ratio of 0.92. This is a neutral value indicating SBRA is somewhat dependend on debt financing.
SBRA has a Debt to Equity ratio of 0.92. This is in the better half of the industry: SBRA outperforms 66.41% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.92 | ||
| Debt/FCF | 168.41 | ||
| Altman-Z | 0.81 |
ROIC/WACC0.56
WACC6.9%
2.3 Liquidity
SBRA has a Current Ratio of 2.48. This indicates that SBRA is financially healthy and has no problem in meeting its short term obligations.
SBRA's Current ratio of 2.48 is amongst the best of the industry. SBRA outperforms 86.72% of its industry peers.
SBRA has a Quick Ratio of 2.48. This indicates that SBRA is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of SBRA (2.48) is better than 86.72% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.48 | ||
| Quick Ratio | 2.48 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 75.61% over the past year.
SBRA shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 9.28% yearly.
The Revenue has grown by 8.88% in the past year. This is quite good.
The Revenue has been growing slightly by 3.41% on average over the past years.
EPS 1Y (TTM)75.61%
EPS 3YN/A
EPS 5Y9.28%
EPS Q2Q%-30.77%
Revenue 1Y (TTM)8.88%
Revenue growth 3Y7.31%
Revenue growth 5Y3.41%
Sales Q2Q%6.76%
3.2 Future
Based on estimates for the next years, SBRA will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.42% on average per year.
Based on estimates for the next years, SBRA will show a quite strong growth in Revenue. The Revenue will grow by 9.62% on average per year.
EPS Next Y47.55%
EPS Next 2Y23.04%
EPS Next 3Y16.42%
EPS Next 5YN/A
Revenue Next Year7.85%
Revenue Next 2Y8.44%
Revenue Next 3Y9.83%
Revenue Next 5Y9.62%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 25.82, the valuation of SBRA can be described as expensive.
Based on the Price/Earnings ratio, SBRA is valued a bit cheaper than 72.66% of the companies in the same industry.
SBRA is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 25.56, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 23.17, which indicates a rather expensive current valuation of SBRA.
SBRA's Price/Forward Earnings ratio is rather cheap when compared to the industry. SBRA is cheaper than 87.50% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 34.62. SBRA is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.82 | ||
| Fwd PE | 23.17 |
4.2 Price Multiples
SBRA's Enterprise Value to EBITDA ratio is in line with the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as SBRA.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 289.72 | ||
| EV/EBITDA | 15.41 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of SBRA may justify a higher PE ratio.
SBRA's earnings are expected to grow with 16.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.54
PEG (5Y)2.78
EPS Next 2Y23.04%
EPS Next 3Y16.42%
5. Dividend
5.1 Amount
SBRA has a Yearly Dividend Yield of 6.42%, which is a nice return.
Compared to an average industry Dividend Yield of 6.49, SBRA pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.44, SBRA pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.42% |
5.2 History
The dividend of SBRA decreases each year by -7.34%.
SBRA has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of SBRA decreased recently.
Dividend Growth(5Y)-7.34%
Div Incr Years0
Div Non Decr Years1
5.3 Sustainability
163.17% of the earnings are spent on dividend by SBRA. This is not a sustainable payout ratio.
DP163.17%
EPS Next 2Y23.04%
EPS Next 3Y16.42%
18.59
-0.06 (-0.32%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners100.95%
Inst Owner Change1.83%
Ins Owners1.03%
Ins Owner Change3.63%
Market Cap4.46B
Revenue(TTM)745.08M
Net Income(TTM)175.08M
Analysts76
Price Target20.91 (12.48%)
Short Float %7.98%
Short Ratio6.48
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.42% |
Yearly Dividend1.2
Dividend Growth(5Y)-7.34%
DP163.17%
Div Incr Years0
Div Non Decr Years1
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.24%
Min EPS beat(2)-51.75%
Max EPS beat(2)51.26%
EPS beat(4)2
Avg EPS beat(4)2.43%
Min EPS beat(4)-51.75%
Max EPS beat(4)51.26%
EPS beat(8)2
Avg EPS beat(8)-14.25%
EPS beat(12)2
Avg EPS beat(12)-67%
EPS beat(16)3
Avg EPS beat(16)-79.33%
Revenue beat(2)1
Avg Revenue beat(2)1.26%
Min Revenue beat(2)-0.25%
Max Revenue beat(2)2.77%
Revenue beat(4)3
Avg Revenue beat(4)0.96%
Min Revenue beat(4)-0.25%
Max Revenue beat(4)2.77%
Revenue beat(8)7
Avg Revenue beat(8)1.58%
Revenue beat(12)8
Avg Revenue beat(12)1.29%
Revenue beat(16)9
Avg Revenue beat(16)-0.42%
PT rev (1m)-0.22%
PT rev (3m)3.44%
EPS NQ rev (1m)0.89%
EPS NQ rev (3m)0.89%
EPS NY rev (1m)3.14%
EPS NY rev (3m)8.75%
Revenue NQ rev (1m)0.87%
Revenue NQ rev (3m)2.55%
Revenue NY rev (1m)0.36%
Revenue NY rev (3m)1.4%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.82 | ||
| Fwd PE | 23.17 | ||
| P/S | 5.98 | ||
| P/FCF | 289.72 | ||
| P/OCF | 13.07 | ||
| P/B | 1.58 | ||
| P/tB | 1.61 | ||
| EV/EBITDA | 15.41 |
EPS(TTM)0.72
EY3.87%
EPS(NY)0.8
Fwd EY4.32%
FCF(TTM)0.06
FCFY0.35%
OCF(TTM)1.42
OCFY7.65%
SpS3.11
BVpS11.78
TBVpS11.53
PEG (NY)0.54
PEG (5Y)2.78
Graham Number13.81
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.15% | ||
| ROE | 6.2% | ||
| ROCE | 4.9% | ||
| ROIC | 3.87% | ||
| ROICexc | 4.02% | ||
| ROICexgc | 4.07% | ||
| OM | 35.78% | ||
| PM (TTM) | 23.5% | ||
| GM | 68.38% | ||
| FCFM | 2.07% |
ROA(3y)0.43%
ROA(5y)0.34%
ROE(3y)0.86%
ROE(5y)0.66%
ROIC(3y)3.52%
ROIC(5y)3.4%
ROICexc(3y)3.55%
ROICexc(5y)3.44%
ROICexgc(3y)3.57%
ROICexgc(5y)3.46%
ROCE(3y)4.45%
ROCE(5y)4.3%
ROICexgc growth 3Y10.05%
ROICexgc growth 5Y1.42%
ROICexc growth 3Y10.2%
ROICexc growth 5Y1.69%
OM growth 3Y-0.95%
OM growth 5Y-4.46%
PM growth 3YN/A
PM growth 5Y9.21%
GM growth 3Y-4.03%
GM growth 5Y-3.89%
F-Score6
Asset Turnover0.13
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.92 | ||
| Debt/FCF | 168.41 | ||
| Debt/EBITDA | 5.83 | ||
| Cap/Depr | 183.12% | ||
| Cap/Sales | 43.72% | ||
| Interest Coverage | 2.51 | ||
| Cash Conversion | 76.75% | ||
| Profit Quality | 8.79% | ||
| Current Ratio | 2.48 | ||
| Quick Ratio | 2.48 | ||
| Altman-Z | 0.81 |
F-Score6
WACC6.9%
ROIC/WACC0.56
Cap/Depr(3y)57.48%
Cap/Depr(5y)56.11%
Cap/Sales(3y)15.43%
Cap/Sales(5y)15.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)75.61%
EPS 3YN/A
EPS 5Y9.28%
EPS Q2Q%-30.77%
EPS Next Y47.55%
EPS Next 2Y23.04%
EPS Next 3Y16.42%
EPS Next 5YN/A
Revenue 1Y (TTM)8.88%
Revenue growth 3Y7.31%
Revenue growth 5Y3.41%
Sales Q2Q%6.76%
Revenue Next Year7.85%
Revenue Next 2Y8.44%
Revenue Next 3Y9.83%
Revenue Next 5Y9.62%
EBIT growth 1Y9.23%
EBIT growth 3Y6.29%
EBIT growth 5Y-1.21%
EBIT Next Year83.79%
EBIT Next 3Y27.39%
EBIT Next 5Y19.52%
FCF growth 1Y-93.63%
FCF growth 3Y-12.17%
FCF growth 5Y-11.54%
OCF growth 1Y17.87%
OCF growth 3Y-4.49%
OCF growth 5Y-3.57%
SABRA HEALTH CARE REIT INC / SBRA FAQ
What is the ChartMill fundamental rating of SABRA HEALTH CARE REIT INC (SBRA) stock?
ChartMill assigns a fundamental rating of 6 / 10 to SBRA.
What is the valuation status for SBRA stock?
ChartMill assigns a valuation rating of 5 / 10 to SABRA HEALTH CARE REIT INC (SBRA). This can be considered as Fairly Valued.
How profitable is SABRA HEALTH CARE REIT INC (SBRA) stock?
SABRA HEALTH CARE REIT INC (SBRA) has a profitability rating of 6 / 10.
Can you provide the PE and PB ratios for SBRA stock?
The Price/Earnings (PE) ratio for SABRA HEALTH CARE REIT INC (SBRA) is 25.82 and the Price/Book (PB) ratio is 1.58.
Can you provide the financial health for SBRA stock?
The financial health rating of SABRA HEALTH CARE REIT INC (SBRA) is 5 / 10.